In the current period, the US egg industry has experienced revenue growth primarily driven by historically high egg prices, a direct consequence of recurrent HPAI outbreaks. These outbreaks have been the most disruptive force over the past five years, leading to significant flock reductions and persistent supply shortages. As millions of hens have been culled due to disease, the scarcity has caused retail egg prices to soar, with some months seeing prices more than double year-over-year. This price surge has helped offset revenue losses from flock reductions but increased input costs for some producers; the overall uneven impact has prompted an industry-wide shift towards improved biosecurity measures and contingency planning to mitigate future risks and maintain current price levels. Overall, revenue has climbed at a CAGR of 15.5% to an estimated $19.8 billion after a decrease of 4.4% in 2025. Trade dynamics and input costs are significantly challenging profit, despite rising egg prices. The US has increased imports to make up for domestic shortages, sourcing eggs from countries less affected by HPAI, like Mexico. However, new tariffs on imports and critical feed ingredients stand to raise costs for US egg producers, diminishing competitiveness abroad and driving higher domestic prices. Retaliatory tariffs, especially from Canada, and increased costs for foreign-manufactured equipment have further strained profit. While elevated egg prices have provided some revenue relief, high input costs, especially for feed, have suppressed overall profit levels across the industry. Looking ahead, the outlook for the US egg industry will be driven by steady production growth and price normalization. With the expected recovery from disease shocks and ongoing investments in capacity expansion, output is projected to rise through 2030, matching climbing per capita egg consumption. As supply stabilizes, egg prices will drop sharply from recent peaks to near pre-HPAI levels by 2026. Consequently, revenue is forecast to decline at a CAGR of 6.0% to reach $14.5 billion in 2030. Nevertheless, specialty eggs like organic and cage-free are expected to maintain stronger margins due to regulatory mandates and evolving consumer preferences. Producers are increasingly investing in operational efficiency initiatives, supported by emerging livestock-care technologies and methods and lower borrowing costs, as they prepare for a more competitive pricing environment while preserving sustainable growth.